Metabolic Gene Polymorphism Frequencies in Control Populations

M. Ingelman-Sundberg , C. Ambrosone , V. Nazar-Stewart , B. Schoket
Cancer Epidemiology, Biomarkers & Prevention 10 ( 12) 1239 -1248

1,117
2001
Comparative Transcriptomics of Prostate Tumor Show Enrichment of Biologically Distinct Pathways Among Men of African Origin

K. Yamoah , F.A. Asamoah , A. Abrahams , S. Awasthi
International Journal of Radiation Oncology Biology Physics 108 ( 3)

2020
Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors.

E. Spangler , C.M. Zeigler-Johnson , S.B. Malkowicz , A.J. Wein
International Journal of Cancer 113 ( 3) 471 -474

15
2005
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

P. Tonin , B. Weber , K. Offit , F. Couch
Nature Medicine 2 ( 11) 1179 -1183

279
1996
2014
Population Frequencies of Single Nucleotide Polymorphisms (SNPs) in Immuno-Modulatory Genes

A.-M. Martin , G. Athanasiadis , J.D. Greshock , J. Fisher
Human Heredity 55 ( 4) 171 -178

34
2003
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

Deborah Ford , DF Easton , M Stratton , S Narod
American Journal of Human Genetics 62 ( 3) 676 -689

3,817
1998
Tubal ligation does not modify ovarian cancer risk in BRCA mutation carriers

J. Chan , M.D. Sammel , T.M. Friebel , C. Gracia
Fertility and Sterility 104 ( 3) e259

1
2015
BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions

V.L. Patel , E. Busch , A.V. D'Amico , T.R. Rebbeck
International Journal of Radiation Oncology*Biology*Physics 96 ( 2) E569 -E570

2016
Clinical Implications of TMPRSS2-ERG Fusion in African American Men With Localized Prostate Cancer

K. Yamoah , P. Lal , S. Mahajan , A.O. Naghavi
International Journal of Radiation Oncology*Biology*Physics 96 ( 2) E569

2016
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

T.R. Rebbeck
European Journal of Cancer 38 ( 6) 15 -17

83
2002
Associations of Stromal Infiltration with Prognosis and Response to Postoperative Radiotherapy in Prostate Cancer

W.S. Chen , B.A. Mahal , M. Alshalalfa , S.G. Zhao
International Journal of Radiation Oncology Biology Physics 105 ( 1)

2019
Conservative Management for Low-Risk Prostate Cancer in Black Patients: A Population-Based Analysis

S.S. Butler , V. Muralidhar , P.L. Nguyen , T.R. Rebbeck
International Journal of Radiation Oncology Biology Physics 105 ( 1)

2019
Erratum: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

T.R. Rebbeck , J.M. Jaffe , A.H. Walker , A.J. Wein
JNCI Journal of the National Cancer Institute 91 ( 12) 1082 -1082

1999
Increased transcriptional activity of the CYP3A4*1B promoter variant

B. Amirimani , B. Ning , A.C. Deitz , B.L. Weber
Environmental and Molecular Mutagenesis 42 ( 4) 299 -305

153
2003
2019
Association of Obesity With Tumor Characteristics and Treatment Failure of Prostate Cancer in African-American and European American Men

E. Spangler , C.M. Zeigler-Johnson , M. Coomes , S.B. Malkowicz
Journal of Urology 178 ( 5) 1939 -1945

48
2007
Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.

C.M. Zeigler-Johnson , A.H. Walker , B. Mancke , E. Spangler
Human Heredity 54 ( 1) 13 -21

84
2002
Predicted germline BRCA1/BRCA2 mutations and second primary ipsilateral breast cancers in young women with pure ductal carcinoma in-situ treated with breast conserving therapy

C.S Kim , A.A Gumbs , L Komarnicky , D Carter
International Journal of Radiation Oncology Biology Physics 48 ( 3) 142 -143

1
2000